<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-056810</identifier>
<setSpec>0365-6691</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Regression of a choroidal metastasis from prostate adenocarcinoma after hormonal therapy</dc:title>
<dc:description xml:lang="en">Case report: We report a case of a patient diagnosed    with prostatic adenocarcinoma with multiple    bone metastases and a choroidal metastasis in his    left eye. Hormonal therapy with an anti-androgen    and a LH-RH agonist was followed by regression of    the choroidal mass over a period of 2 months. No    metastatic recurrence has been demonstrated after a    follow-up period of 14 months.    Discussion: Complete resolution of choroidal    metastases of prostatic adenocarcinoma with hormonal    therapy is exceptional, but the effect of this    treatment on such metastases should be observed    before recommending radiation therapy</dc:description>
<dc:creator>Pérez-García, F. J</dc:creator>
<dc:creator>Sampedro, A</dc:creator>
<dc:creator>Barbón, J. J</dc:creator>
<dc:creator>Gay, LL</dc:creator>
<dc:creator>González-Tuero, J</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Caso clínico: Paciente diagnosticado de adenocarcinoma    de próstata con múltiples metástasis óseas,    que también presentaba una gran metástasis coroidea    en su ojo izquierdo. El tratamiento hormonal,    mediante la asociación de un antiandrógeno y un    análogo de LH-RH, obtuvo en 2 meses una rápida    regresión de la metástasis, regresión que se mantiene    a los 14 meses de seguimiento.    Discusión: La desaparición de las metástasis coroideas    en el adenocarcinoma de próstata con la terapia    hormonal resulta excepcional aunque su efecto    podría probarse antes de pautar la radioterapia    como tratamiento electivo</dc:description>
<dc:source>Arch Soc Esp Oftalmol;82(11): 715-718, nov. 2007. ilus</dc:source>
<dc:identifier>ibc-056810</dc:identifier>
<dc:title xml:lang="es">Regresión de una metástasis coroidea de adenocarcinoma de próstata con tratamiento hormonal</dc:title>
<dc:subject>^d238^s22012</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d6885^s22020</dc:subject>
<dc:subject>^d9555^s22032</dc:subject>
<dc:subject>^d2879^s29166</dc:subject>
<dc:subject>^d11914^s22012</dc:subject>
<dc:subject>^d11914^s22067</dc:subject>
<dc:subject>^d974^s22020</dc:subject>
<dc:subject>^d6885^s22073</dc:subject>
<dc:subject>^d32835^s22020</dc:subject>
<dc:subject>^d2879^s22053</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:subject>^d9555^s22053</dc:subject>
<dc:subject>^d32835^s22073</dc:subject>
<dc:type>article</dc:type>
<dc:date>200711</dc:date>
</metadata>
</record>
</ibecs-document>
